Pharmacogenetics, drug-metabolizing enzymes, and clinical practice SJ Gardiner, EJ Begg Pharmacological reviews 58 (3), 521-590, 2006 | 552 | 2006 |
Aminoglycosides--50 years on. EJ Begg, ML Barclay British journal of clinical pharmacology 39 (6), 597, 1995 | 431 | 1995 |
Drugs in human milk: clinical pharmacokinetic considerations HC Atkinson, EJ Begg, BA Darlow Clinical pharmacokinetics 14, 217-240, 1988 | 258 | 1988 |
Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph PA Bird, EJ Begg, M Zhang, AT Keast, DP Murray, TJ Balkany Otology & Neurotology 28 (8), 1124-1130, 2007 | 257 | 2007 |
A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression RL Roberts, PR Joyce, RT Mulder, EJ Begg, MA Kennedy The pharmacogenomics journal 2 (3), 191-196, 2002 | 241 | 2002 |
A suggested approach to once‐daily aminoglycoside dosing. EJ Begg, ML Barclay, SB Duffull British journal of clinical pharmacology 39 (6), 605-609, 1995 | 231 | 1995 |
Distribution and excretion of fluoxetine and norfluoxetine in human milk Kristensen, Ilett, Hackett, Yapp, Paech, Begg British journal of clinical pharmacology 48 (4), 521-527, 1999 | 213 | 1999 |
Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people TJ Wilkinson, EJ Begg, AC Winter, R Sainsbury British journal of clinical pharmacology 47 (2), 211-217, 1999 | 204 | 1999 |
The therapeutic monitoring of antimicrobial agents EJ Begg, ML Barclay, CMJ Kirkpatrick British Journal of Clinical Pharmacology 52 (S1), 35-43, 2001 | 170 | 2001 |
Prediction of drug distribution into human milk from physicochemical characteristics UC Atkinson, EJ Begg Clinical pharmacokinetics 18, 151-167, 1990 | 169 | 1990 |
Free drug metabolic clearance in elderly people JM Butler, EJ Begg Clinical Pharmacokinetics 47, 297-321, 2008 | 162 | 2008 |
Once daily aminoglycoside therapy: is it less toxic than multiple daily doses and how should it be monitored? ML Barclay, CMJ Kirkpatrick, EJ Begg Clinical pharmacokinetics 36, 89-98, 1999 | 150 | 1999 |
Adaptive resistance following single doses of gentamicin in a dynamic in vitro model ML Barclay, EJ Begg, ST Chambers Antimicrobial agents and chemotherapy 36 (9), 1951-1957, 1992 | 150 | 1992 |
Studying drugs in human milk: time to unify the approach EJ Begg, SB Duffull, LP Hackett, KF Ilett Journal of Human Lactation 18 (4), 323-332, 2002 | 141 | 2002 |
Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph PA Bird, DP Murray, M Zhang, EJ Begg Otology & Neurotology 32 (6), 933-936, 2011 | 135 | 2011 |
What is the evidence for once-daily aminoglycoside therapy? ML Barclay, EJ Begg, KG Hickling Clinical pharmacokinetics 27, 32-48, 1994 | 131 | 1994 |
Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice? SJ Gardiner, EJ Begg Pharmacogenetics and genomics 15 (5), 365-369, 2005 | 119 | 2005 |
Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants SJ Gardiner, JH Kristensen, EJ Begg, LP Hackett, DA Wilson, KF Ilett, ... American Journal of Psychiatry 160 (8), 1428-1431, 2003 | 118 | 2003 |
Rapid and simple high-performance liquid chromatographic assay for the determination of metformin in human plasma and breast milk M Zhang, GA Moore, M Lever, SJ Gardiner, CMJ Kirkpatrick, EJ Begg Journal of Chromatography B 766 (1), 175-179, 2002 | 117 | 2002 |
Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother‐infant pairs SJ Gardiner, RB Gearry, RL Roberts, M Zhang, ML Barclay, EJ Begg British journal of clinical pharmacology 62 (4), 453-456, 2006 | 116 | 2006 |